The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-(4-(5-(4-hydroxy-2-methoxyphenyl)-1,3,4-oxadiazol-2-yl)phenyl)-1,3,4-thia-diazol-2-yl)benzene-1,4-diol ID: ALA4565724
PubChem CID: 155560145
Max Phase: Preclinical
Molecular Formula: C23H16N4O5S
Molecular Weight: 460.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(O)ccc1-c1nnc(-c2ccc(-c3nnc(-c4cc(O)ccc4O)s3)cc2)o1
Standard InChI: InChI=1S/C23H16N4O5S/c1-31-19-11-15(29)6-8-16(19)21-25-24-20(32-21)12-2-4-13(5-3-12)22-26-27-23(33-22)17-10-14(28)7-9-18(17)30/h2-11,28-30H,1H3
Standard InChI Key: IYRMDXYWLSNSFW-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
10.8945 -10.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8933 -10.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6014 -11.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3110 -10.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3082 -10.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5996 -9.5996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1853 -11.2361 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5971 -8.7824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8882 -8.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0121 -9.5953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7599 -9.9248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3044 -9.3155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8932 -8.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0367 -8.7823 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2196 -7.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0332 -7.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3628 -7.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8797 -6.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0634 -6.4605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7376 -7.2077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2046 -5.6222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0030 -5.4481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0842 -4.6350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3359 -4.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7924 -4.8877 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.1714 -3.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7835 -2.9658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6195 -2.1660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8434 -1.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2309 -2.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3980 -3.2527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5585 -3.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4546 -2.1998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
6 8 1 0
8 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
5 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
13 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
18 21 1 0
24 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
27 32 1 0
30 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 460.47Molecular Weight (Monoisotopic): 460.0841AlogP: 4.71#Rotatable Bonds: 5Polar Surface Area: 134.62Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.25CX Basic pKa: ┄CX LogP: 3.76CX LogD: 3.70Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.32Np Likeness Score: -0.35
References 1. Taha M, Imran S, Alomari M, Rahim F, Wadood A, Mosaddik A, Uddin N, Gollapalli M, Alqahtani MA, Bamarouf YA.. (2019) Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study., 27 (14): [PMID:31196753 ] [10.1016/j.bmc.2019.05.049 ]